Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (SAH): a Prospective Observational Study

NCT07614906 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07614906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07614906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (SAH): a Prospective Observational Study
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2024
Completion date
June 30, 2027
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, cerebral vasospasm